Soc. Generale Knock-Out BIO/ DE000SW22NW2 /
19/11/2024 17:48:41 | Diferencia0.00 | Bid17:59:45 | Ask17:59:45 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.97EUR | 0.00% | 1.97 Volumen de oferta: 35,000 |
2.03 Tamaño/ Volumen/ Formato de Ask: 35,000 |
Bio Rad Laboratories... | 524.3507 USD | 31/12/2078 | Put |
GlobeNewswire
12/08
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
24/06
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
03/06
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
29/03/2022
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
22/03/2022
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
03/08/2021
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
01/06/2021
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
24/08/2020
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
04/05/2020
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
16/04/2020
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
20/03/2020
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
Newsfile Corp
09/03/2020
Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página